94 results
Page 2 of 5
8-K
EX-1.1
u89v6doprdytxt7
12 Oct 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:46pm
424B5
yjzbi e9r
8 Oct 21
Prospectus supplement for primary offering
5:13pm
424B5
ku7g1nxsnk119 sdc
6 Oct 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-10.1
yaqhhavya90xc7m7z4w
6 Oct 21
Entry into a Material Definitive Agreement
4:22pm
8-K
EX-1.1
avyeoxq kg1s53j5ja
8 Sep 21
Other Events
7:10am
424B5
qx6u91s
8 Sep 21
Prospectus supplement for primary offering
7:01am
8-K
EX-99.3
q04io0821
8 Sep 21
Other Events
6:22am
8-K
EX-99.2
1zg4yxe3abdx 2p7k12f
8 Sep 21
Other Events
6:22am
8-K
EX-2.1
b870 psvt8v8t4
30 Jun 21
Osmotica Pharmaceuticals plc Announces Conclusion of Strategic Process with Agreement for the Sale of Legacy Business to Alora Pharmaceuticals, LLC
6:04am
8-K
EX-99.1
6t6p1ix7b9f0hp
30 Mar 21
Osmotica Pharmaceuticals plc Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
12:00am
8-K
EX-99.1
7i5v1d569fvgu8
10 Nov 20
Osmotica Pharmaceuticals plc Reports Third Quarter 2020 Results and Provides Business Updates
4:23pm
8-K
EX-99.2
t4z7mu
11 Aug 20
Osmotica Pharmaceuticals plc Reports Second Quarter 2020 Results and Provides Business Updates
4:40pm